Recurrent or Metastatic Lung Cancer Clinical Trials in Guangzhou, Guangdong

Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung Cancer Patients: a Single-arm, Prospective, Open-label Phase II Clinical Study